On September 29, 2025, Silo Pharma, Inc. agreed to sell 2,857,143 shares of common stock at $0.875 each to institutional investors, aiming for around $2.5 million in gross proceeds for working capital. The offering includes warrants for investors to purchase additional shares at $0.75 per share, closing on October 1, 2025.